Showing results (1621-1630 of 1,713) with videos related to
Sort By:
Pageof 172
JMIR Research Protocols|November 22, 2017
Pulmonary Rehabilitation With Balance Training for Fall Reduction in Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Controlled TrialMarla K Beauchamp, Dina Brooks, Cindy Ellerton, et al.Journal of Medicinal Chemistry|July 5, 2022
SAGE-718: A First-in-Class <i>N</i>-Methyl-d-Aspartate Receptor Positive Allosteric Modulator for the Potential Treatment of Cognitive ImpairmentMatthew D Hill, Maria-Jesus Blanco, Francesco G Salituro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high doseMichelle L Harrison, Eva Obermueller, Nick R Maisey, et al.The Gerontologist|July 28, 2025
"It may cost you your money, it costs you your life": a framework for financial hardship in dementiaKrista L Harrison, Emily R Adrion, Juliana Friend, et al.Journal of Medicinal Chemistry|August 8, 2019
Neuroactive Steroid <i>N</i>-Methyl-d-aspartate Receptor Positive Allosteric Modulators: Synthesis, SAR, and Pharmacological ActivityDaniel S La, Francesco G Salituro, Gabriel Martinez Botella, et al.Journal of the American Geriatrics Society|November 19, 2016
Predicting Risk of Cognitive Decline in Very Old Adults Using Three Models: The Framingham Stroke Risk Profile; the Cardiovascular Risk Factors, Aging, and Dementia Model; and Oxi-Inflammatory BiomarkersStephanie L Harrison, Anton J M de Craen, Ngaire Kerse, et al.Journal of Medicinal Chemistry|March 24, 2015
Neuroactive Steroids. 1. Positive Allosteric Modulators of the (γ-Aminobutyric Acid)A Receptor: Structure-Activity Relationships of Heterocyclic Substitution at C-21Gabriel Martinez Botella, Francesco G Salituro, Boyd L Harrison, et al.Bioorganic & Medicinal Chemistry|October 20, 2009
3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3Lisa M Havran, Dan C Chong, Wayne E Childers, et al.Sports Medicine (Auckland, N.Z.)|June 6, 2019
Exercise Recommendations for Women with Polycystic Ovary Syndrome: Is the Evidence Enough?Nigel K Stepto, Rhiannon K Patten, Eliza C Tassone, et al.Journal of Medicinal Chemistry|July 29, 2017
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)<sub>A</sub> ReceptorGabriel Martinez Botella, Francesco G Salituro, Boyd L Harrison, et al.Pageof 172